FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years – Endpoints News

FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years  Endpoints NewsFDA Approvals Are up, But Timing Is a Challenge in 2026  Medical Device and Diagnostic industryRegulatory Actions for June 2026  PharmTech.comFDA Clears More Devices in H1 2026 But Timelines Slip  ZenopaFDA News Recap: Novel Drug Approvals in Q2 2026  HCPLive